Validating Predictive Models and Biomarkers of Radiotherapy Toxicity to Reduce Side-Effects and Improve Quality of Life in Cancer Survivors

El propósito de este estudio internacional es tratar de predecir qué pacientes son más propensos a desarrollar efectos adversos tras la radioterapia

News

REQUITE on Facebook

Annual REQUITE Consortium Meeting June 20-21st, 2017!

The 5th REQUITE Annual Consortium Meeting will be held 20-21st June 2017, hosted by Vall d’Hebron Institute of Oncology (VHIO) in Barcelona, Spain. This will be held in conjunction with the International Radiogenomics Consortium annual meeting on 19th June. Many of the researchers involved in the REQUITE project are also part of the Radiogenomics consortium. A good reason to combine both yearly meetings at one moment of the year in the same venue, giving the involved people the opportunity to attend both meetings.

9th Annual Radiogenomics consortium meeting in Barcelona.

The Radiogenomics Consortium was established in November 2009. The scientific hypothesis underlying the development of the consortium is that a cancer patient's likelihood of developing toxicity to radiation therapy is influenced by common genetic variations, such as single nucleotide polymorphisms (SNPs).

The Consortium members undertake collaborative projects to identify SNPs associated with adverse effects following radiotherapy, share data and samples, perform meta-analyses, and work together to submit research grant applications.

REQUITE paper published in the Green Journal.

The REQUITE paper "Optimal design and patient selection for interventional trials using radiogenomic biomarkers: A REQUITE and Radiogenomics consortium statement", De Ruysscher D, Defraene G, Ramaekers BL, Lambin P, Briers E, Stobart H, Ward T, Bentzen SM, Van Staa T, Azria D, Rosenstein B, Kerns S, West C  has been published in the Green Journal, December 2016 Volume 121, Issue 3, Pages 440–446. 

The Green Journal is the Journal of the European SocieTy for Radiotherapy & Oncology.

Older news

Recruitment

Breast
2071
Lung
559
Prostate
1810

Events

5th Annual REQUITE Consortium Meeting and 9th Annual Radiogenomics Consortium Meeting

The 5th REQUITE Annual Consortium Meeting will be held 20-21st June 2017 at Vall d’Hebron Institute of Oncology (VHIO) in Barcelona, Spain www.vhio.net. As in previous years, this will be held in conjunction with the International Radiogenomics Consortium annual meeting on 19th June.

Dates: 
Monday, 19 June, 2017 to Wednesday, 21 June, 2017
Location: 
Vall d’Hebron Institute of Oncology (VHIO), CELLEX CENTER
C/ Natzaret, 115-117
08035 Barcelona
Spain
ES